Analyst Jonathan Chang from Leerink Partners reiterated a Buy rating on Zai Lab (ZLAB – Research Report) and keeping the price target at ...

Limited announced that it has commenced an underwritten public offering of $200M of American depositary shares, ADSs, each ...

SHANGHAI & CAMBRIDGE, Mass., November 13, 2024--(BUSINESS WIRE)--Zai Lab Limited ("Zai Lab" or the "Company") (NASDAQ: ZLAB; ...

You need to be a subscriber to view this content.

at 16:15 Zai Lab Announces Proposed Public Offering of American Depositary Shares Zai Lab Limited ("Zai Lab" or the "Company") , an innovative, commercial-stage biopharmaceutical company, today ...

Zai Lab Limited ("Zai Lab" or the "Company") , an innovative, commercial-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of $200.0 million of ...

Asian equities traded in the US as American depositary receipts were lower Wednesday morning, down 0.89% at 2,026.12 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by computer ...

KINGSOFT CLOUD (03896) HK$2.160 -8.47 - Active selling orders account for 42% ZAI LAB (09688) HK$22.900 -6.34 - Active selling orders account for 31% ...

再鼎医药现在的股价报30.89 再鼎医药的股票在哪间交易所挂牌交易？ 再鼎医药的股票在纳斯达克挂牌交易。 再鼎医药的股票代码是什么？ 再鼎医药的股票代码是“ZLAB。” 再鼎医药的市值是多少？ 截至今天，再鼎医药的市值是2.84B。 再鼎医药的每股收益(EPS)是 ...

06911 LANCANG TEA Circulars - (Change in Auditors subject to Shareholders' Approval) 06911 LANCANG TEA Announcements and Notices - (Change in Auditors / Notice of EGM/SGM / Closure of Books or Change ...

In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.